Intro

This chapter explores the issues leading to the failure of MDMA-assisted psychotherapy for PTSD, including boundary violations and functional unblinding. It discusses the recent FDA panel's rejection of the therapy, clinical trial challenges, and the potential influence of therapists on patient outcomes.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app